These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


256 related items for PubMed ID: 22303527

  • 1. Epidemiology of gout and chondrocalcinosis.
    Ciancio G, Bortoluzzi A, Govoni M.
    Reumatismo; 2012 Jan 19; 63(4):207-20. PubMed ID: 22303527
    [Abstract] [Full Text] [Related]

  • 2. Crystal arthritides - gout and calcium pyrophosphate arthritis : Part 1: Epidemiology and pathophysiology.
    Schlee S, Bollheimer LC, Bertsch T, Sieber CC, Härle P.
    Z Gerontol Geriatr; 2018 Jun 19; 51(4):453-460. PubMed ID: 28233117
    [Abstract] [Full Text] [Related]

  • 3. Metabolism of crystals within the joint.
    Oliviero F, Scanu A, Punzi L.
    Reumatismo; 2012 Jan 19; 63(4):221-9. PubMed ID: 22303528
    [Abstract] [Full Text] [Related]

  • 4. Comorbidities in patients with crystal diseases and hyperuricemia.
    Sattui SE, Singh JA, Gaffo AL.
    Rheum Dis Clin North Am; 2014 May 19; 40(2):251-78. PubMed ID: 24703346
    [Abstract] [Full Text] [Related]

  • 5. An update on the epidemiology of calcium pyrophosphate dihydrate crystal deposition disease.
    Richette P, Bardin T, Doherty M.
    Rheumatology (Oxford); 2009 Jul 19; 48(7):711-5. PubMed ID: 19398486
    [Abstract] [Full Text] [Related]

  • 6. [Epidemiology and risk factors for gout].
    Gnjidić Z.
    Reumatizam; 2012 Jul 19; 59(2):82-8. PubMed ID: 23745462
    [Abstract] [Full Text] [Related]

  • 7. The changing epidemiology of gout.
    Roddy E, Zhang W, Doherty M.
    Nat Clin Pract Rheumatol; 2007 Aug 19; 3(8):443-9. PubMed ID: 17664951
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Epidemiology of hyperuricemia and gout.
    Luk AJ, Simkin PA.
    Am J Manag Care; 2005 Nov 19; 11(15 Suppl):S435-42; quiz S465-8. PubMed ID: 16300457
    [Abstract] [Full Text] [Related]

  • 10. Cardiovascular and renal effects of hyperuricaemia and gout.
    Viazzi F, Leoncini G, Pontremoli R.
    Reumatismo; 2012 Jan 19; 63(4):253-62. PubMed ID: 22303532
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Chondrocalcinosis].
    Fallet GH, Vischer TL, Micheli A.
    Schweiz Med Wochenschr; 1982 Jun 19; 112(25):888-97. PubMed ID: 7112058
    [Abstract] [Full Text] [Related]

  • 19. Inflammation and tissue damage in crystal deposition diseases.
    Dalbeth N, Haskard DO.
    Curr Opin Rheumatol; 2005 May 19; 17(3):314-8. PubMed ID: 15838243
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.